* Tectonic Therapeutic Inc TECX.OQ reported a quarterly
adjusted
loss of $4.34 per share for the quarter ended in June, higher
than the same quarter last year, when the company reported EPS
of $-4.44. The mean expectation of three analysts for the
quarter was for a loss of $1.50 per share. Wall Street expected
results to range from $-3.00 tozero cents per share.
* Reported revenue was zero; analysts expected zero.
* Tectonic Therapeutic Inc's reported EPS for the quarter
was a
loss of $4.34.
* The company reported a quarterly loss of $12.67 million.
* Tectonic Therapeutic Inc shares had risen by 2.6% this
quarter and gained 3.6% so far this year.
FORECAST CHANGES
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Tectonic
Therapeutic Inc is $62.50
This summary was machine generated from LSEG data August 16 at
09:21 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -1.50 -4.34 Missed
Mar. 31 2024 -4.32 -1.80 Beat
Dec. 31 2023 -4.04 -2.40 Beat
Sep. 30 2023 -3.40 -5.28 Missed